Effect of laser Therapy in Tempromandibular Joint Disorders
- Conditions
- Tempromandibular Joint disorders.Temporomandibular joint disordersM26.6
- Registration Number
- IRCT20180224038840N3
- Lead Sponsor
- Oroumia University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 34
limited mouth opening or function
presence of pain in masticatory muscles and/or TMJs, either in clenching or in jaw movements (TMD muscular disturbance (class Ia, Ib) or arthralgia (class IIIa).
patients who had major systemic disorders
patients who received analgesic or anti-depressant over the last 2 weeks
patients who had any bony abnormalities of the jaws such as arthropathy of the TMJ or rheumatoid arthritis
Patients with psychological illness
patients who received any form of treatment for TMD within the last month
pregnant and feeding patients
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The number of pain intensity on visual analogue scale (VAS). Timepoint: Measurement of pain intensity before the intervention, 2 weeks and 4 weeks after the start of the intervention and 1 month after the end of the treatment sessions. Method of measurement: visual analogue scale (VAS).
- Secondary Outcome Measures
Name Time Method Amount of mouth opening. Timepoint: Measurement of pain intensity before the intervention, 2 weeks and 4 weeks after the start of the intervention and 1 month after the end of the treatment sessions. Method of measurement: Digital ruler.;The amount of deviation while opening the mouth. Timepoint: Measurement of pain intensity before the intervention, 2 weeks and 4 weeks after the start of the intervention and 1 month after the end of the treatment sessions. Method of measurement: Observation.;Satisfaction with treatment. Timepoint: In the last session of laser treatment. Method of measurement: questionnaire.;Click sound. Timepoint: Measurement of pain intensity before the intervention, 2 weeks and 4 weeks after the start of the intervention and 1 month after the end of the treatment sessions. Method of measurement: Hearing.